PFS Investments’s Halozyme HALO Stock Holding History

PFS Investments’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-96,560	Closed	-$3.7M	–	522
2023 Q1	$3.7M	Buy	96,560 +35,718	+59%	+$1.68M	0.06%	247
2022 Q4	$3.46M	Buy	+60,842	New	+$3.12M	0.06%	234

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

PFS Investments's HALO Position: Q2 2023 in Review

PFS Investments sold out of Halozyme (HALO) in Q2 2023, closing a stake of 96,560 shares — an estimated $3.7M sold.

PFS Investments first reported a position in HALO in Q4 2022 and held it in 2 quarters. The position peaked at $3.7M in Q1 2023. 370 funds tracked by Wall St. Rank hold HALO as of Q2 2023.

PFS Investments reported no remaining Halozyme position as of Q2 2023 after selling out during the quarter.
PFS Investments sold 96,560 Halozyme shares in Q2 2023, an estimated $3.7M.
PFS Investments first reported a position in Halozyme in Q4 2022 and held it in 2 quarters.
PFS Investments's Halozyme position peaked at $3.7M in Q1 2023.
370 funds tracked by Wall St. Rank held Halozyme as of Q2 2023.

Based on PFS Investments's 13F filing for Q2 2023, filed 14 Aug 2023.